Scutellarin, a flavonoid glucuronide, is an active ingredient of breviscapine. It can be widely used in the treatment of cerebral infarction, coronary heart disease and angina pectoris.
The global market for Scutellarin was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Plant sources include the leaves of Scutellaria altissima L, the stem and leaves of Scutellaria altissima L, and the whole herb of Scutellaria altissima (S. Barbara D. Don). It has the functions of reducing cerebrovascular resistance, improving cerebral blood circulation, increasing cerebral blood flow and anti-platelet aggregation. It is clinically used for the treatment of paralysis after cerebrovascular disease.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Scutellarin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Scutellarin by region & country, by Type, and by Application.
The Scutellarin market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Scutellarin.
Market Segmentation
By Company
Pu RuiSi
YuanYe
J&K
Xi Li
Pu RuiFa
DaoLan
TongTian
Target Mol
Rui FenSi
Bidel
MacLin
KangNuo
Solarbio
HeGu
Boc Sciences
TargetMol
Cayman Chemical Company
Matrix Scientific
JR MediChem
ChemScene
CSNpharm
Cfm Oskar Tropitzsch
GLR Innovations
Carbosynth
Leancare
Apin Chemicals
Segment by Type:
98% Purity
99% Purity
Segment by Application
Medical
Life Sciences
Health Products
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Scutellarin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Scutellarin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Scutellarin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Scutellarin Product Introduction
1.2 Global Scutellarin Market Size Forecast
1.2.1 Global Scutellarin Sales Value (2019-2030)
1.2.2 Global Scutellarin Sales Volume (2019-2030)
1.2.3 Global Scutellarin Sales Price (2019-2030)
1.3 Scutellarin Market Trends & Drivers
1.3.1 Scutellarin Industry Trends
1.3.2 Scutellarin Market Drivers & Opportunity
1.3.3 Scutellarin Market Challenges
1.3.4 Scutellarin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Scutellarin Players Revenue Ranking (2023)
2.2 Global Scutellarin Revenue by Company (2019-2024)
2.3 Global Scutellarin Players Sales Volume Ranking (2023)
2.4 Global Scutellarin Sales Volume by Company Players (2019-2024)
2.5 Global Scutellarin Average Price by Company (2019-2024)
2.6 Key Manufacturers Scutellarin Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Scutellarin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Scutellarin
2.9 Scutellarin Market Competitive Analysis
2.9.1 Scutellarin Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Scutellarin Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Scutellarin as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 98% Purity
3.1.2 99% Purity
3.2 Global Scutellarin Sales Value by Type
3.2.1 Global Scutellarin Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Scutellarin Sales Value, by Type (2019-2030)
3.2.3 Global Scutellarin Sales Value, by Type (%) (2019-2030)
3.3 Global Scutellarin Sales Volume by Type
3.3.1 Global Scutellarin Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Scutellarin Sales Volume, by Type (2019-2030)
3.3.3 Global Scutellarin Sales Volume, by Type (%) (2019-2030)
3.4 Global Scutellarin Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medical
4.1.2 Life Sciences
4.1.3 Health Products
4.2 Global Scutellarin Sales Value by Application
4.2.1 Global Scutellarin Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Scutellarin Sales Value, by Application (2019-2030)
4.2.3 Global Scutellarin Sales Value, by Application (%) (2019-2030)
4.3 Global Scutellarin Sales Volume by Application
4.3.1 Global Scutellarin Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Scutellarin Sales Volume, by Application (2019-2030)
4.3.3 Global Scutellarin Sales Volume, by Application (%) (2019-2030)
4.4 Global Scutellarin Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Scutellarin Sales Value by Region
5.1.1 Global Scutellarin Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Scutellarin Sales Value by Region (2019-2024)
5.1.3 Global Scutellarin Sales Value by Region (2025-2030)
5.1.4 Global Scutellarin Sales Value by Region (%), (2019-2030)
5.2 Global Scutellarin Sales Volume by Region
5.2.1 Global Scutellarin Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Scutellarin Sales Volume by Region (2019-2024)
5.2.3 Global Scutellarin Sales Volume by Region (2025-2030)
5.2.4 Global Scutellarin Sales Volume by Region (%), (2019-2030)
5.3 Global Scutellarin Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Scutellarin Sales Value, 2019-2030
5.4.2 North America Scutellarin Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Scutellarin Sales Value, 2019-2030
5.5.2 Europe Scutellarin Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Scutellarin Sales Value, 2019-2030
5.6.2 Asia Pacific Scutellarin Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Scutellarin Sales Value, 2019-2030
5.7.2 South America Scutellarin Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Scutellarin Sales Value, 2019-2030
5.8.2 Middle East & Africa Scutellarin Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Scutellarin Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Scutellarin Sales Value
6.2.1 Key Countries/Regions Scutellarin Sales Value, 2019-2030
6.2.2 Key Countries/Regions Scutellarin Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Scutellarin Sales Value, 2019-2030
6.3.2 United States Scutellarin Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Scutellarin Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Scutellarin Sales Value, 2019-2030
6.4.2 Europe Scutellarin Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Scutellarin Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Scutellarin Sales Value, 2019-2030
6.5.2 China Scutellarin Sales Value by Type (%), 2023 VS 2030
6.5.3 China Scutellarin Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Scutellarin Sales Value, 2019-2030
6.6.2 Japan Scutellarin Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Scutellarin Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Scutellarin Sales Value, 2019-2030
6.7.2 South Korea Scutellarin Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Scutellarin Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Scutellarin Sales Value, 2019-2030
6.8.2 Southeast Asia Scutellarin Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Scutellarin Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Scutellarin Sales Value, 2019-2030
6.9.2 India Scutellarin Sales Value by Type (%), 2023 VS 2030
6.9.3 India Scutellarin Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pu RuiSi
7.1.1 Pu RuiSi Company Information
7.1.2 Pu RuiSi Introduction and Business Overview
7.1.3 Pu RuiSi Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Pu RuiSi Scutellarin Product Offerings
7.1.5 Pu RuiSi Recent Development
7.2 YuanYe
7.2.1 YuanYe Company Information
7.2.2 YuanYe Introduction and Business Overview
7.2.3 YuanYe Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.2.4 YuanYe Scutellarin Product Offerings
7.2.5 YuanYe Recent Development
7.3 J&K
7.3.1 J&K Company Information
7.3.2 J&K Introduction and Business Overview
7.3.3 J&K Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.3.4 J&K Scutellarin Product Offerings
7.3.5 J&K Recent Development
7.4 Xi Li
7.4.1 Xi Li Company Information
7.4.2 Xi Li Introduction and Business Overview
7.4.3 Xi Li Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Xi Li Scutellarin Product Offerings
7.4.5 Xi Li Recent Development
7.5 Pu RuiFa
7.5.1 Pu RuiFa Company Information
7.5.2 Pu RuiFa Introduction and Business Overview
7.5.3 Pu RuiFa Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Pu RuiFa Scutellarin Product Offerings
7.5.5 Pu RuiFa Recent Development
7.6 DaoLan
7.6.1 DaoLan Company Information
7.6.2 DaoLan Introduction and Business Overview
7.6.3 DaoLan Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.6.4 DaoLan Scutellarin Product Offerings
7.6.5 DaoLan Recent Development
7.7 TongTian
7.7.1 TongTian Company Information
7.7.2 TongTian Introduction and Business Overview
7.7.3 TongTian Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.7.4 TongTian Scutellarin Product Offerings
7.7.5 TongTian Recent Development
7.8 Target Mol
7.8.1 Target Mol Company Information
7.8.2 Target Mol Introduction and Business Overview
7.8.3 Target Mol Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Target Mol Scutellarin Product Offerings
7.8.5 Target Mol Recent Development
7.9 Rui FenSi
7.9.1 Rui FenSi Company Information
7.9.2 Rui FenSi Introduction and Business Overview
7.9.3 Rui FenSi Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Rui FenSi Scutellarin Product Offerings
7.9.5 Rui FenSi Recent Development
7.10 Bidel
7.10.1 Bidel Company Information
7.10.2 Bidel Introduction and Business Overview
7.10.3 Bidel Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Bidel Scutellarin Product Offerings
7.10.5 Bidel Recent Development
7.11 MacLin
7.11.1 MacLin Company Information
7.11.2 MacLin Introduction and Business Overview
7.11.3 MacLin Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.11.4 MacLin Scutellarin Product Offerings
7.11.5 MacLin Recent Development
7.12 KangNuo
7.12.1 KangNuo Company Information
7.12.2 KangNuo Introduction and Business Overview
7.12.3 KangNuo Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.12.4 KangNuo Scutellarin Product Offerings
7.12.5 KangNuo Recent Development
7.13 Solarbio
7.13.1 Solarbio Company Information
7.13.2 Solarbio Introduction and Business Overview
7.13.3 Solarbio Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Solarbio Scutellarin Product Offerings
7.13.5 Solarbio Recent Development
7.14 HeGu
7.14.1 HeGu Company Information
7.14.2 HeGu Introduction and Business Overview
7.14.3 HeGu Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.14.4 HeGu Scutellarin Product Offerings
7.14.5 HeGu Recent Development
7.15 Boc Sciences
7.15.1 Boc Sciences Company Information
7.15.2 Boc Sciences Introduction and Business Overview
7.15.3 Boc Sciences Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Boc Sciences Scutellarin Product Offerings
7.15.5 Boc Sciences Recent Development
7.16 TargetMol
7.16.1 TargetMol Company Information
7.16.2 TargetMol Introduction and Business Overview
7.16.3 TargetMol Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.16.4 TargetMol Scutellarin Product Offerings
7.16.5 TargetMol Recent Development
7.17 Cayman Chemical Company
7.17.1 Cayman Chemical Company Company Information
7.17.2 Cayman Chemical Company Introduction and Business Overview
7.17.3 Cayman Chemical Company Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Cayman Chemical Company Scutellarin Product Offerings
7.17.5 Cayman Chemical Company Recent Development
7.18 Matrix Scientific
7.18.1 Matrix Scientific Company Information
7.18.2 Matrix Scientific Introduction and Business Overview
7.18.3 Matrix Scientific Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Matrix Scientific Scutellarin Product Offerings
7.18.5 Matrix Scientific Recent Development
7.19 JR MediChem
7.19.1 JR MediChem Company Information
7.19.2 JR MediChem Introduction and Business Overview
7.19.3 JR MediChem Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.19.4 JR MediChem Scutellarin Product Offerings
7.19.5 JR MediChem Recent Development
7.20 ChemScene
7.20.1 ChemScene Company Information
7.20.2 ChemScene Introduction and Business Overview
7.20.3 ChemScene Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.20.4 ChemScene Scutellarin Product Offerings
7.20.5 ChemScene Recent Development
7.21 CSNpharm
7.21.1 CSNpharm Company Information
7.21.2 CSNpharm Introduction and Business Overview
7.21.3 CSNpharm Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.21.4 CSNpharm Scutellarin Product Offerings
7.21.5 CSNpharm Recent Development
7.22 Cfm Oskar Tropitzsch
7.22.1 Cfm Oskar Tropitzsch Company Information
7.22.2 Cfm Oskar Tropitzsch Introduction and Business Overview
7.22.3 Cfm Oskar Tropitzsch Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.22.4 Cfm Oskar Tropitzsch Scutellarin Product Offerings
7.22.5 Cfm Oskar Tropitzsch Recent Development
7.23 GLR Innovations
7.23.1 GLR Innovations Company Information
7.23.2 GLR Innovations Introduction and Business Overview
7.23.3 GLR Innovations Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.23.4 GLR Innovations Scutellarin Product Offerings
7.23.5 GLR Innovations Recent Development
7.24 Carbosynth
7.24.1 Carbosynth Company Information
7.24.2 Carbosynth Introduction and Business Overview
7.24.3 Carbosynth Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.24.4 Carbosynth Scutellarin Product Offerings
7.24.5 Carbosynth Recent Development
7.25 Leancare
7.25.1 Leancare Company Information
7.25.2 Leancare Introduction and Business Overview
7.25.3 Leancare Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.25.4 Leancare Scutellarin Product Offerings
7.25.5 Leancare Recent Development
7.26 Apin Chemicals
7.26.1 Apin Chemicals Company Information
7.26.2 Apin Chemicals Introduction and Business Overview
7.26.3 Apin Chemicals Scutellarin Sales, Revenue and Gross Margin (2019-2024)
7.26.4 Apin Chemicals Scutellarin Product Offerings
7.26.5 Apin Chemicals Recent Development
8 Industry Chain Analysis
8.1 Scutellarin Industrial Chain
8.2 Scutellarin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Scutellarin Sales Model
8.5.2 Sales Channel
8.5.3 Scutellarin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Pu RuiSi
YuanYe
J&K
Xi Li
Pu RuiFa
DaoLan
TongTian
Target Mol
Rui FenSi
Bidel
MacLin
KangNuo
Solarbio
HeGu
Boc Sciences
TargetMol
Cayman Chemical Company
Matrix Scientific
JR MediChem
ChemScene
CSNpharm
Cfm Oskar Tropitzsch
GLR Innovations
Carbosynth
Leancare
Apin Chemicals
听
听
*If Applicable.